InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 378

Saturday, 11/05/2022 2:30:42 PM

Saturday, November 05, 2022 2:30:42 PM

Post# of 404
PRGN-3005: They moved forward with testing DL3 plus LD chemo prior to IV infusion. Also, are able to incorporate repeat dosing. Based on the previous data, as well as this, I don't hold out much hope.

PRGN-3006: Another year has passed and only nine additional patients have been treated. Worse still, none have responded.

PRGN-3007: Not only haven't they dosed the first patient, but the trial isn't even listed on the clinicaltrials website.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PGEN News